From: MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-κB axis
Variable | Overall survival | |||
---|---|---|---|---|
Univariate analysis | Multivariate analysis | |||
HR | 95% CI | HR | 95% CI | |
Gender | ||||
Male | 1.507 | 0.617–3.68 | 1.289 | 0.515–3.226 |
Female | 1 | 1 | ||
Age (y) | ||||
≤61 | 0.898 | 0.444–1.819 | 0.847 | 0.414–1.732 |
>61 | 1 | 1 | ||
Primary tumor (T) stage | ||||
T1-T2 | 0.785 | 0.368–1.674 | 0.759 | 0.351–1.641 |
T3-T4 | 1 | 1 | ||
Lymph node (N) classificaction | ||||
N0–1 | 0.418* | 0.205–0.851 | 0.532 | 0.252–1.124 |
N2–3 | 1 | 1 | ||
Neoplasm histologic grade | ||||
G1-G2 | 0.739 | 0.348–1.572 | 0.838 | 0.382–1.837 |
G3-G4 | 1 | 1 | ||
Mir-19b-3p expression level | ||||
Low | 0.3* | 0.104–0.863 | 0.337* | 0.114–0.992 |
High | 1 | 1 |